Use of antifungal drugs in pregnancy. A focus on safety

Drug Safety

Volumn 23, Issue 1, 2000, Pages 77-85

  Sobel, Jack D ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Henry Ford Health System Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BUTOCONAZOLE; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; FLUCYTOSINE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; POTASSIUM IODIDE; PYRROLE DERIVATIVE; TERBINAFINE; TERCONAZOLE;

AMNION FLUID; CENTRAL NERVOUS SYSTEM DISEASE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRUG USE; EMBRYOTOXICITY; FEMALE; FETUS DEVELOPMENT; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LIVER TOXICITY; MYCOSIS; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SPOROTRICHOSIS; TERATOGENESIS; UMBILICAL CORD BLOOD; VAGINA CANDIDIASIS;

EID: 0033948257     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200023010-00005     Document Type: Review

References (45)

1. 1. Federal Register. 1980; 44: 37434-67
2. 2. Sobel JD. Epidemiology and pathogenesis of recurrent vulvo-vaginal candidiasis. Am J Obstet Gynecol 1985; 152: 924-35
3. 3. Candidosis of the genitalia. Odds FC, editor. Candida and candidosis. A review and bibliography. 2nd ed. London: Bailliere Tindall Publishers, 1988: 124-35
4. 4. Cotch MF, Hillier SL, Gibbs RS, et al. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Am J Ob Gyn 1998; 178: 374
5. 5. Mazor M, Chaim W, Shinwell ES, et al. A symptomatic anmiotic fluid invasion with Candida albicans in preterm premature rupture of membranes. Implications for obstetric and neonatal management. Acta Obstet et Gynecol Scand 1993; 72: 52-4
6. 6. Donders GG, Moerman P, Caudron J, et al. Intrauterine Candida infection: a report of four infected fetuses from two mothers. Eur J Obstet Gynecol Reprod Biol 1991; 38: 233-8
7. 7. Shalev E, Battino S, Romano S, et al. Intraamniotic infection with Candida albicans successfully treated with transcervical amnioinfusion of amphotericin. Am J Obstet Gynecol 1994; 170: 1271-2
8. 8. Burns DN, Tuomala R, Chang BH, et al. Vaginal colonization or infection with Candida albicans in HIV-infected women during pregnancy and during the postpartum period. Women and Infants Transmission Study Group. Clin Infect Dis 1997; 24: 201-10
9. 9. Catanzaro A. Pulmonary mycosis in pregnant women. Chest 1984; 86 Suppl. 3: 145-85
10. 10. Rodrigues J, Niederman MS. Pneumonia complicating pregnancy. Clin Chest Med 1992; 13: 679-91
11. 11. Hager H, Welt SI, Cardasis JP, et al. Disseminated blastomycosis in a pregnant women successfully treated with amphotericin B. J Reprod Med 1988; 33: 485-8
12. 12. Ismail MA, Lerner SA. Disseminated blastomycosis in a pregnant women: review of amphotericin B usage during pregnancy. Am Rev Respir Dis 1982; 126: 350-3
13. 13. Blotta MH, Altemani AN, Amaral E, et al. Placental involvement in paracoccidioidomycosis. J Med Vet Mycol 1993; 31: 249-57
14. 14. MacDonald D, Alguire PC. Adult respiratory distress syndrome due to blastomycosis during pregnancy. Chest 1990; 98: 1527-8
15. 15. Daniel L, Salit IT. Blastomycosis during pregnancy. Can Med Assoc J 1984; 131: 759-61
16. 16. McGregor JA, Kleinschmidt-De Masters BK, Ogle J. Meningoencephalitis caused by Histoplasma capsulatum complicating pregnancy. Am J Obstet Gynecol 1986; 154: 925-31
17. 17. Ely EW, Peacock Jr JE, Haponik EF, et al. Cryptococcal pneumonia complicating pregnancy. Medicine 1998; 77: 15-67
18. 18. Saade GR. Human immunodeficiency virus (HIV)-related pulmonary complications in pregnancy. Semin Perinatol 1997; 21 : 336-50
19. 19. Elewski BE. Superficial mycoses, dermatophytoses and selected dermatomycoses. In: Elewski BE, editor. Topics in clinical dermatology: cutaneous fungal infections. New York (NY): Igakin-Shoin, 1992: 12-68
20. 20. Chow AW, Jewesson PJ. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect dis 1985; 7:287-313
21. 21. King CT, Rogers PD, Cleary JD, et al. Antifungal therapy during pregnancy. Clin Infect Dis 1998; 27: 1151-60
22. 22. Lasher Jr JL. Therapeutic agents for dermatologic fungal diseases. In: Elewski B, editor. Topics in clinical dermatology: cutaneous fungal infections. Tokyo: Igaku-Shoin, 1992: 229-41
23. 23. Frerich W, Gad B. The frequency of Candida infections in pregnancy and their treatment with clotrimazole. Curr Med Res Opin 1977; 4: 640-4
24. 24. Aleck KA, Bartley DL. Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet 1997; 72: 253-6
25. 25. Pursley TJ, Blomquist IK, Abraham J, et al. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 1996; 22: 336-40
26. 26. Jick SS. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy 1999; 19: 221-2
27. 27. Mastroiacovo P, Mazzone T, Botto LD, et al. Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am J Obstet Gynecol 1996; 175: 1645-50
28. 28. Wallenburg HC, Wladimiroff JUB. Recurrence of vulvovaginal candidosis during pregnancy. Comparison of miconazole vs. nystatin treatment. Obstet Gynecol 1976; 48: 491-4
29. 29. Lang WR, Stella JG, Bendrakan V. Nystatin vaginal tablets in the treatment of candidal vulvovaginitis. Obstet Gynecol 1965; 8: 364-7
30. 30. Guidelines for treatment of sexually transmitted disease. MMWR Morb Mortal Wkly Rep 1998; 47 RR-1: 75-9
31. 31. McNellis D, McLeod M, Lawson J, et al. Treatment of vulvovaginal candidiasis in pregnancy: a comparative study. Obstet Gynecol 1977; 50: 674-8
32. 32. Weisberg M. Treatment of vaginal candidiasis in pregnant women. Clin Ther 1986; 8: 563-7
33. 33. Higashide K, Kawaguchi C, Tomoda Y. Three-day clotrimazole therapy for vulvovaginal mycoses. J Int Med Res 1983; 11 : 21-7
34. 34. Haram K, Digranes A. Vulvovaginal candidiasis in pregnancy treated with clotrimazole. Acta Obstet Gynecol Scand 1978; 57: 453-5
35. 35. Rosa FW, Baum C, Shaw M. Pregnancy outcomes after first trimester vaginitis drug therapy. Obstet Gynecol 1987; 69: 751-5
36. 36. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203-11
37. 37. Wiesinger EC, Mayerhofer S, Wenisch C, et al. Fluconazole in Candida albicans sepsis during pregnancy: case report and review of the literature. Infection 1996; 24: 263-6
38. 38. Vanderveen EE, Messenger AL, Voorhees JJ. Sporotrichosis in pregnancy. Cutis 1982; 30: 761-3
39. 39. Bennett JE. Flucytoin. Ann Intern Med 1977; 86: 319-22
40. 40. Chen CP, Wang K. Cryptococcal meningitis in pregnancy. Am J Perinatal 1996; 13: 35-6
41. 41. Van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the aquired immunodeficiency syndrome. N Engl J Med 1997; 337: 15-21
42. 42. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000; 30 (4): 662-78
43. 43. Dean JL, Wolf JE, Ranzini AC, et al. Use of amphotericin B during pregnancy: case report and review. Clin Infect Dis 1994; 18: 364-8
44. 44. Kauffman CA, Carver PL. Use of azoles for systemic antifungal therapy. Adv Pharmacol 1997; 39: 143-89
45. 45. Tiboni GM. Second brachial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos. Res Commun Chem Pathol Pharmacol 1993; 79: 381-4